Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3
Clinical trial NCT03937882 · COMPLETED
Trial details
- NCT number
- NCT03937882
- Sponsor
- ReGenTree, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-24
- Primary completion
- 2020-11-08
- Enrollment
- 700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.